Luteolin enhances cell viability and inhibits apoptosis by downregulating the matrix metalloproteinase 9 expression and activating the PI3K/AKT-mediated mTOR and GSK3β pathways, which alleviate cerebral infarction (40). This evidence concerns the gene AKT1 and cerebral infarction.